ADORA2A and Alzheimer disease: Therefore, this review will focus on a survey of recent literature on the A2A adenosine receptor as a druggable target for another important neurodegenerative disorder, i.e., Alzheimer’s disease (AD), considering the present technological state and directions for improving drug discovery and development from both biological and chemical perspectives.